Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression

Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression

Background: Intravenous (IV) ketamine is a rapid acting antidepressant used primarily for treatment-resistant depression (TRD). It has been suggested that IV ketamine’s rapid antidepressant effects may be partially mediated via improved sleep and changes to the circadian rhythm. Objectives: This stu...

ver descrição completa

Detalhes bibliográficos
Principais autores: Raymond Yan, Tyler Marshall, Atul Khullar, Travis Nagle, Jake Knowles, Mai Malkin, Brittany Chubbs, Jennifer Swainson
Formato: Artigo
Idioma:English
Publicado em: SAGE Publishing 2024-03-01
coleção:Therapeutic Advances in Psychopharmacology
Acesso em linha:https://doi.org/10.1177/20451253241231264

Internet

https://doi.org/10.1177/20451253241231264

Registros relacionados